Center-Authored Papers

Filters: Author is Cooney, Kathleen A  [Clear All Filters]
Journal Article
Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, Cannon-Albright LA, Farnham JM, George A, Powell I et al..  2012.  Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.. BMC medical genetics. 13(1):46. Abstract
Teerlink CC, Thibodeau SN, McDonnell SK, Schaid DJ, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O et al..  2014.  Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.. Human genetics. 133(3):347-56. Abstract
Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu J-N, Bauer S, Van Blarigan EL, Chen X et al..  2015.  Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.. Human genetics. 134(4):439-50. Abstract
Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TLJ et al..  2012.  Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG.. The Prostate. 72(4):410-426. Abstract
Hovelson DH, McDaniel AS, Cani AK, Johnson B, Rhodes K, Williams PD, Bandla S, Bien G, Choppa P, Hyland F et al..  2015.  Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.. Neoplasia (New York, N.Y.). 17(4):385-99. Abstract
Teerlink CC, Leongamornlert D, Dadaev T, Thomas A, Farnham J, Stephenson RA, Riska S, McDonnell SK, Schaid DJ, Catalona WJ et al..  2016.  Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.. Human genetics. Abstract
Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL et al..  2011.  Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.. Nature genetics. 43(6):570-3. Abstract
Christensen BG, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR et al..  2010.  Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses.. The Prostate. 70(7):735-44. Abstract
Larson NB, McDonnell S, Albright LC, Teerlink C, Stanford J, Ostrander EA, Isaacs WB, Xu J, Cooney KA, Lange E et al..  2017.  gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernels.. Genetic epidemiology. Abstract
Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM et al..  2013.  HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).. Human genetics. 132(1):5-14. Abstract
Tischkowitz MD, Yilmaz A, Chen LQ, Karyadi DM, Novak D, Kirchhoff T, Hamel N, Tavtigian SV, Kolb S, Bismar TA et al..  2008.  Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer.. Cancer letters. 270(1):173-80. Abstract
Eeles RA, Al Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S et al..  2013.  Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.. Nature genetics. 45(4):385-91,391e1-2. Abstract
Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA et al..  2009.  Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.. Nature genetics. 41(10):1116-21. Abstract
Robinson D, Van Allen EM, Wu Y-M, Schultz N, Lonigro RJ, Mosquera J-M, Montgomery B, Taplin M-E, Pritchard CC, Attard G et al..  2015.  Integrative clinical genomics of advanced prostate cancer.. Cell. 161(5):1215-28. Abstract
Al Olama AA, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC et al..  2013.  A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.. Human molecular genetics. 22(2):408-15. Abstract
Larson NB, McDonnell S, Albright LC, Teerlink C, Stanford J, Ostrander EA, Isaacs WB, Xu J, Cooney KA, Lange E et al..  2016.  Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies.. Genetic epidemiology. 40(6):461-469. Abstract
Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, Musolf A, Li Q, Holzinger E, Karyadi D et al..  2016.  REVEL: an Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.. American journal of human genetics. 99(4):877-885. Abstract
Kote-Jarai Z, Al Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H et al..  2011.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.. Nature genetics. 43(8):785-791. Abstract
Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM et al..  2012.  Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).. Human genetics. 131(7):1095-1103. Abstract